Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas
Open Access
- 1 January 2017
- journal article
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 28 (3) , e33
Abstract
Miyamoto M, et al. J Gynecol Oncol. 2017 Mar;28(3):e33. https://doi.org/10.3802/jgo.2017.28.e33Keywords
This publication has 21 references indexed in Scilit:
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatmentCell Death & Disease, 2013
- Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic reviewJournal of Gynecologic Oncology, 2013
- The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancerThe Journal of Pathology, 2012
- Autophagy as a mediator of chemotherapy-induced cell death in cancerBiochemical Pharmacology, 2011
- NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic responseOncogene, 2011
- Prognostic factors for high‐risk early‐stage epithelial ovarian cancerCancer, 2008
- Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2008
- Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2007
- Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical stagingBritish Journal of Cancer, 2006
- Development by Self-DigestionDevelopmental Cell, 2004